Page 3 - Cancer Update Spring 2019 Vol. 8 Issue 1

BAYLOR SCOTT & WHITE ONCOLOGY
Cancer research studies at Baylor Charles A. Sammons Cancer Center, located
on the campus of Baylor University Medical Center, are conducted through Baylor Scott & White Research Institute, Texas Oncology and U.S. Oncology. Each reviews, approves and conducts clinical trials independently.
HOSPITAL-BASED CANCER PROGRAMS
Baylor Scott & White Health has the largest network of hospital-based cancer programs in Texas with 16 cancer centers.
NORTH TEXAS
Carrollton Dallas Frisco
Fort Worth Grapevine Irving
Lake Pointe McKinney Plano Waxahachie
CENTRAL TEXAS
College Station Killeen
Marble Falls Round Rock Temple
Waco
2 4 8 11
13 20 23 24 26 28
1
CONTENTS
From the Medical Director
Baylor Charles A. Sammons Cancer Center Current Clinical Trials Innovative Immuno-Oncology Clinical Trial Using Natural Killer Cells What Are Neuroendocrine Tumors?
A Multidisciplinary Approach to Neuroendocrine Cancer
Heritable Neuroendocrine Tumors
Neuroendocrine Cancer in the Skin: Merkel Cell Carcinoma
Peptide Receptor Radionuclide Therapy
Living Donor Liver Transplant for Neuroendocrine Cancer
Recent Publications from Baylor Charles A. Sammons Cancer Center
For more information, call 214.820.3535 or visit us at BSWH.md/Oncology. If you do not wish to receive future mailings from Baylor Scott & White Health, please call 1.844.BSW.DOCS.
Photography may include models or actors and may not represent actual patients. Physicians provide clinical services as members of the medical staff at one of Baylor Scott & White Health’s subsidiary, community or affiliated medical centers and do not provide clinical services as employees or agents of those medical centers, Baylor Health Care System, Scott & White Healthcare or Baylor Scott & White Health. ©2019 Baylor Scott & White Health. BSWMCD_164_2018 BID